293 related articles for article (PubMed ID: 25495707)
1. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
Li Z; Jiang N; Xu Y
Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
[TBL] [Abstract][Full Text] [Related]
2. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
[No Abstract] [Full Text] [Related]
3. [Capecitabine-induced subacute cutaneous lupus: a case report].
Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
[TBL] [Abstract][Full Text] [Related]
4. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
[TBL] [Abstract][Full Text] [Related]
5. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
Shakhbazova A; Marsch AF
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
[TBL] [Abstract][Full Text] [Related]
6. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
[No Abstract] [Full Text] [Related]
7. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
[No Abstract] [Full Text] [Related]
8. Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings.
Montero-Menárguez J; Gutiérrez-Collar C; Puerta-Peña M; Mitsunaga K; Peralto JLR; Velasco-Tamariz V
Dermatol Ther; 2022 Sep; 35(9):e15705. PubMed ID: 35808972
[No Abstract] [Full Text] [Related]
9. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
Ko JH; Hsieh CI; Chou CY; Wang KH
J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
[No Abstract] [Full Text] [Related]
10. Subacute cutaneous lupus erythematosus induced by capecitabine.
Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
[No Abstract] [Full Text] [Related]
11. Involvement of scars in capecitabine induced hand foot syndrome.
Singh BSTP; Tripathy T; Kar BR; Singh S
Indian J Dermatol Venereol Leprol; 2018; 84(1):85-87. PubMed ID: 29210360
[No Abstract] [Full Text] [Related]
12. Unilateral Capecitabine-related Hand-foot Syndrome.
Matsuda S; Koketsu H; Hayakawa M; Nagata N
Intern Med; 2015; 54(21):2779. PubMed ID: 26521911
[No Abstract] [Full Text] [Related]
13. Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent.
Kim WI; Kim JM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e163-e164. PubMed ID: 26551520
[No Abstract] [Full Text] [Related]
14. Differential expression of capecitabine-induced hand foot syndrome on paretic limb.
Tripathy T; Singh BS; Behera D; Kar BR
Indian J Dermatol Venereol Leprol; 2018; 84(6):720-722. PubMed ID: 30246703
[No Abstract] [Full Text] [Related]
15. Palmar-plantar erythrodysesthesia associated with capecitabine chemotherapy: a case report.
Kigen G; Busakhala N; Njiru E; Chite F; Loehrer P
Pan Afr Med J; 2015; 21():228. PubMed ID: 26523170
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
Callen JP
JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
[No Abstract] [Full Text] [Related]
17. Unusual scrotal and penile ulcerations together with palmar-plantar erythrodysesthesia syndrome in a patient with metastatic colon carcinoma treated with capecitabine.
Ljubojevic Hadzavdic S; Stulhofer Buzina D; Murtezani I; Skerlev M
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):e304-e306. PubMed ID: 27987319
[No Abstract] [Full Text] [Related]
18. Possible Pathways of Capecitabine-Induced Hand-Foot Syndrome.
Lou Y; Wang Q; Zheng J; Hu H; Liu L; Hong D; Zeng S
Chem Res Toxicol; 2016 Oct; 29(10):1591-1601. PubMed ID: 27631426
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine-Related Eruption Mimicking Dermatomyositis in 2 Patients With Metastatic Breast Cancer.
Cobos GA; Nelson CA; Alsarheed A; LaChance A; Laga AC; LeBoeuf N; Vleugels RA
JAMA Dermatol; 2020 Jan; 156(1):103-104. PubMed ID: 31693064
[No Abstract] [Full Text] [Related]
20. Curcuma longa (Turmeric) for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Pilot Study.
Scontre VA; Martins JC; de Melo Sette CV; Mutti H; Cubero D; Fonseca F; Del Giglio A
J Diet Suppl; 2018 Sep; 15(5):606-612. PubMed ID: 29095653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
